In the HCC cells overexpressing FABP5 treated with the CREB inhibitor KG-501, CREB phosphorylation were significantly decreased compared with the untreated FABP5 overexpression group (Figure 8d). The gene discussed is FABP5; the disease is hepatocellular carcinoma.